Andrew J. Wang

Array ( [id] => 3805574 [patent_doc_number] => 05854067 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-29 [patent_title] => 'Hexokinase inhibitors' [patent_app_type] => 1 [patent_app_number] => 8/588983 [patent_app_country] => US [patent_app_date] => 1996-01-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 39560 [patent_no_of_claims] => 64 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 77 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/854/05854067.pdf [firstpage_image] =>[orig_patent_app_number] => 588983 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4041761 [patent_doc_number] => 05874304 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-02-23 [patent_title] => 'Humanized green fluorescent protein genes and methods' [patent_app_type] => 1 [patent_app_number] => 8/588201 [patent_app_country] => US [patent_app_date] => 1996-01-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 26 [patent_no_of_words] => 33324 [patent_no_of_claims] => 81 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/874/05874304.pdf [firstpage_image] =>[orig_patent_app_number] => 588201 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3773243 [patent_doc_number] => 05849904 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-15 [patent_title] => 'Isolated nucleic acid molecules which hybridize to polysialyl transferases' [patent_app_type] => 1 [patent_app_number] => 8/576775 [patent_app_country] => US [patent_app_date] => 1995-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 23 [patent_no_of_words] => 17057 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/849/05849904.pdf [firstpage_image] =>[orig_patent_app_number] => 576775 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4006307 [patent_doc_number] => 05962224 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-10-05 [patent_title] => 'Isolated DNA encoding p62 polypeptides and uses therefor' [patent_app_type] => 1 [patent_app_number] => 8/574959 [patent_app_country] => US [patent_app_date] => 1995-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 52 [patent_figures_cnt] => 32 [patent_no_of_words] => 43097 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/962/05962224.pdf [firstpage_image] =>[orig_patent_app_number] => 574959 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3827239 [patent_doc_number] => 05738991 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-04-14 [patent_title] => 'Method of detecting elastase IV' [patent_app_type] => 1 [patent_app_number] => 8/568031 [patent_app_country] => US [patent_app_date] => 1995-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 12132 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/738/05738991.pdf [firstpage_image] =>[orig_patent_app_number] => 568031 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4047017 [patent_doc_number] => 05968818 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-10-19 [patent_title] => 'Lipoprotein associated phospholipase A2, inhibitors thereof and use of the same in diagnosis and therapy' [patent_app_type] => 1 [patent_app_number] => 8/557892 [patent_app_country] => US [patent_app_date] => 1995-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 8932 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/968/05968818.pdf [firstpage_image] =>[orig_patent_app_number] => 557892 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3999708 [patent_doc_number] => 05858774 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-01-12 [patent_title] => 'Antisense DNA constructs for expression of hybrid MRNAs driven by inducible, tissue-specific promoters' [patent_app_type] => 1 [patent_app_number] => 8/543559 [patent_app_country] => US [patent_app_date] => 1995-10-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 11 [patent_no_of_words] => 6892 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 78 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/858/05858774.pdf [firstpage_image] =>[orig_patent_app_number] => 543559 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3880910 [patent_doc_number] => 05798237 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-08-25 [patent_title] => 'Recombinant lactobacillus for fermentation of xylose to lactic acid and lactate' [patent_app_type] => 1 [patent_app_number] => 8/541632 [patent_app_country] => US [patent_app_date] => 1995-10-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 6106 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/798/05798237.pdf [firstpage_image] =>[orig_patent_app_number] => 541632 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4151308 [patent_doc_number] => 06107027 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-08-22 [patent_title] => 'Ribozymes for treating hepatitis C' [patent_app_type] => 1 [patent_app_number] => 8/534220 [patent_app_country] => US [patent_app_date] => 1995-09-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 5 [patent_no_of_words] => 9009 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/107/06107027.pdf [firstpage_image] =>[orig_patent_app_number] => 534220 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4029761 [patent_doc_number] => 05855911 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-01-05 [patent_title] => 'Liposomal phosphodiester, phosphorothioate, and P-ethoxy oligonucleotides' [patent_app_type] => 1 [patent_app_number] => 8/520385 [patent_app_country] => US [patent_app_date] => 1995-08-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 9 [patent_no_of_words] => 4306 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 123 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/855/05855911.pdf [firstpage_image] =>[orig_patent_app_number] => 520385 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3982417 [patent_doc_number] => 05861309 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-01-19 [patent_title] => 'DNA endoding human alpha 1 adrenergic receptors' [patent_app_type] => 1 [patent_app_number] => 8/406855 [patent_app_country] => US [patent_app_date] => 1995-08-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 37 [patent_figures_cnt] => 38 [patent_no_of_words] => 28115 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/861/05861309.pdf [firstpage_image] =>[orig_patent_app_number] => 406855 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3728467 [patent_doc_number] => 05700924 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-12-23 [patent_title] => 'Serpin derived from human hypothalamus' [patent_app_type] => 1 [patent_app_number] => 8/487823 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 12154 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/700/05700924.pdf [firstpage_image] =>[orig_patent_app_number] => 487823 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3648008 [patent_doc_number] => 05683987 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-11-04 [patent_title] => 'Therapeutic oligonucleotides targeting the human MDR1 and MRP genes' [patent_app_type] => 1 [patent_app_number] => 8/487141 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 17675 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/683/05683987.pdf [firstpage_image] =>[orig_patent_app_number] => 487141 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3619473 [patent_doc_number] => 05688676 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-11-18 [patent_title] => 'In vitro packaging of adeno-associated virus DNA' [patent_app_type] => 1 [patent_app_number] => 8/477511 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 9599 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 78 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/688/05688676.pdf [firstpage_image] =>[orig_patent_app_number] => 477511 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3874141 [patent_doc_number] => 05747299 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-05-05 [patent_title] => 'Anergy genes' [patent_app_type] => 1 [patent_app_number] => 8/486955 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5449 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/747/05747299.pdf [firstpage_image] =>[orig_patent_app_number] => 486955 [rel_patent_id] =>[rel_patent_doc_number] =>)